Skip to content

Neuroscience Hospital Aro Abeokuta

Brain Research

  • Home
  • Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics
  • Distributors

Tag: Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease

Enzyme substitute remedy (ERT) can positively have an effect on the visceral manifestations of lysosomal storage illnesses (LSDs). However, the […]

Recent Posts

  • Compare Pcr lab reagents for research
  • Expression of selenoproteins via genetic code expansion in mammalian cells
  • Characterization of guanine nucleotide exchange activity of DH domain of human FGD2
  • Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study
  • Quantum dot thermometry at ultra-low temperature in a dilution refrigerator with a 4He immersion cell.

Recent Comments

    Categories

    • A Collaborative Tele-Neurology Outpatient Consulation Service in Karnataka: Seven Years of Experience From a Tele-Medicine Center
    • Asymmetrical Bioimpedance in the Anterior Circulation for Urgent Stratification of suspected Stroke (ABACUS Stroke): study protocol for a diagnostic accuracy study
    • Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation for dementia with Lewy bodies A Randomised Clinical Trial
    • Mechanical thrombectomy in stroke – planning for service expansion using discrete event simulation
    • Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease
    • Uncategorized
    Copyright © All rights reserved.Theme MagPress by Sensational Theme